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Using a multimodal biospectroscopic approach, we settle several long-standing controversies over the molecular
mechanisms that lead to brain damage in cerebral malaria, which is a major health concern in developing countries
because of high levels of mortality and permanent brain damage. Our results provide the first conclusive evidence
that important components of the pathology of cerebral malaria include peroxidative stress and protein oxidation
within cerebellar gray matter, which are colocalized with elevated nonheme iron at the site of microhemorrhage.
Such information could not be obtained previously from routine imaging methods, such as electron microscopy,
fluorescence, and optical microscopy in combination with immunocytochemistry, or from bulk assays, where the
level of spatial information is restricted to the minimum size of tissue that can be dissected. We describe the novel
combination of chemical probe–free, multimodal imaging to quantify molecular markers of disturbed energy
metabolism and peroxidative stress, which were used to provide new insights into understanding the pathogenesis
of cerebral malaria. In addition to these mechanistic insights, the approach described acts as a template for the
future use of multimodal biospectroscopy for understanding the molecular processes involved in a range of





Malaria is amajor global health and economical problem, and although
annual fatalities are decreasing, approximately 584,000 global deaths
(themajority of which are children younger than 5 years) were reported
by the World Health Organization in the 2014 World Malaria Report
(1). Cerebral malaria (CM) is a neurological complication of malarial
infection and a large contributor to malarial fatalities, with a similar
number of survivors retaining long-term neurological deficits (2). CM
ismost common in children younger than 5 years in sub-SaharanAfrica
and adults in parts of Southeast Asia. The disease always exhibits severe
neurological symptoms, such as blurred vision, impaired consciousness,
and convulsions, which may proceed to coma and death (3, 4). Poor
understanding of the specific biochemical mechanisms that contribute
to the development of disease pathogenesis currently hinders any
improvement in patient therapy.
Although much remains unknown about the chemical pathways
through which CM causes mortality, an increased level of lactate
in the cerebrospinal fluid (CSF) has been identified as a clinical prog-
nostic marker in both advanced human CM and murine experimental
cerebral malaria (ECM) (5–10). The pathology of ECM shares many
similaritieswith the human condition, andpostmortem studies of humanvictims and ECM reveal characteristic histological features that include
sequestration of parasitized red blood cells (PRBCs) and immune
cells (leukocytes, monocytes) within the cerebral bloodmicrovessels,
decreased patency of the blood-brain barrier (BBB) accompanied by
edema, and microhemorrhage (4, 11–13). These findings suggest that
elevated cerebral lactate is a direct consequence of ischemia, which
results from vascular obstruction and/or hemorrhage. However,
contributions from direct effects of proinflammatory cytokines are
possible (7).
It is known that hemorrhage results in substantially increased
cerebral Fe, which, alongside ischemia, results in peroxidative stress
in disorders, such as stroke (14). Because cerebral ischemia and micro-
hemorrhage are components of CM pathogenesis, this led to the
hypothesis that reactive oxygen species, peroxidative stress, and
protein oxidation are key components of CM pathogenesis (15, 16).
Indeed, antioxidant administration before presentation of clinical signs
in ECM prevents the disease (17). However, antioxidant treatment
administered after the onset of clinical symptoms does not prevent
or reduce illness, and biochemical analysis of brain homogenates
provides no evidence of increased protein oxidation during ECM
(18). These results appear to indicate that peroxidative stress is not
a key player in CM pathogenesis and that the positive effect observed
by early administration of antioxidants is the result of actions on an-
other pathway, such as the inflammatory response (17, 18). However,
it is possible that peroxidative damage occurs at discrete foci around
microhemorrhage, and the critical biochemical alterations responsible
for altered brain function are too dilute in a tissue homogenate for
detection. Thus, the critical question of whether peroxidative stress
is a key component of CM pathogenesis has remained unanswered
until now.1 of 13









Although traditional biochemical approaches, such as assays, nuclear
magnetic resonance (NMR) spectroscopy, high-performance liquid
chromatography, and mass spectrometry, are crucial for the quantifi-
cation of specific metabolites in biological samples, they provide
this information at the whole-tissue level (7, 19). Small yet critical
biochemical alterations at the cellular level may not be detected
when analysis is performed on tissue homogenates. Advances in
technology have provided mass spectroscopic imaging modalities,
but these are not applicable at the cellular level (20). Traditional
imaging methods, such as electron microscopy, fluorescence, and
optical microscopy in combination with immunocytochemistry,
suffer serious limitations for direct quantification of important
markers of peroxidative stress. For example, histochemical stains for
Fe do not detect heme Fe and display varied specificity and sensitivity
between ferric and ferrous states (21). Qualitative localization of highly
concentrated regions of b sheet aggregates, such as amyloid-b plaques,
can be performed with thioflavin S/T, Congo red dyes, or immu-
nocytochemistry with antibodies specific for amyloid-b (22). However,
no method is available for semiquantitative localization of non–
plaque-bound aggregated proteins that may be formed during protein
oxidation (23, 24). Similarly, lactate, which is a marker of hypoxic
metabolism and a mobile water-soluble metabolite, cannot be studied
using histology or immunocytochemistry. Although lactate can be
investigated in vivo using NMR spectroscopy, determination at
spatial resolution relevant to microvasculature (~10 mm) is not possible
(6, 7, 19, 25). Conventional microscopy techniques are well suited to
studying alterations in cell structure as a consequence of disease or the
location of specific enzymes implicated in cerebral metabolism [for
example, lactate dehydrogenase (LDH)] and oxidative stress (glutathi-
one reductase). However, the large discrepancy in spatial resolution
between microscopy and techniques capable of direct quantification
of metabolites and oxidation products means correlation between data
obtained by both approaches is speculative, at best. This is an important
reason behind the uncertainty in discerning aspects of the biochemical
mechanisms that contribute to CM and other neurodegenerative
diseases. Therefore, a novel multimodal imaging approach that
provides the ability to image heme and nonheme Fe, aggregated
proteins, and lactate, at the cellular level, would be of great benefit
to studies of CM pathogenesis, and neurodegenerative diseases in
general.
Several chemical probe–free spectroscopic modalities show great
potential for application to the neuroimaging field: Fourier transform
infrared microscopy (FTIRM), resonance Raman spectroscopy, x-ray
fluorescence microscopy (XFM), particle-induced x-ray emission
(PIXE) spectroscopy, scanning transmission ion microscopy, and
Rutherford backscattering (26–33). FTIRM is highly sensitive to
protein secondary structure and has found numerous applications
in imaging increased aggregated b sheet proteins within degenerating
neurons, lesions, and plaques in Alzheimer’s disease (34), Parkinson’s
disease (35), multiple sclerosis (36), and prion-diseased tissue (37), and
following seizures (38). The method has also been used to map locations
of elevated lactate in cerebral tumors (39) and to image lactate within
cerebellar Purkinje neurons (28).
Nondestructive FTIRM can be combined with complementary
resonance Raman spectroscopy, PIXE, and XFM in multimodal imag-
ing (26, 27, 34). XFM and PIXE elemental mapping have found
widespread applications for monitoring changes in brain chemistry
in an array of neurological conditions [for example, stroke (33),Hackett et al. Sci. Adv. 2015;1:e1500911 18 December 2015Alzheimer’s disease (34), Parkinson’s disease (40), prion disease
(41), and epilepsy (42)]. In addition, resonance Raman spectroscopy,
which takes advantage of the preferential enhanced sensitivity to Fe
coordinated in a heme environment, has been used to image the
distribution of hemoglobin in vascular tissue (43–45). Unfortunately,
a large portion of these publications reported results that may be
compromised by inappropriate sample preparation, such as formalin
fixation and paraffin embedding. Although these methods preserve
cellular architecture, they cause significant alterations in molecular
and elemental distribution, and oxidation state, within tissues (30).
Further, although it is common to use FTIRM and XFM methods in
biochemical investigations (34), no previous study has used a suite of
spectroscopic techniques in combination with traditional microscopy
and biochemical methods to take full advantage of their complementary
nature.
In this investigation, FTIRM, PIXE, XFM, and resonance Raman
spectroscopy were used to map or image biochemical alterations at the
cellular or near-cellular level within the cerebellum that resulted from
murine CM and to correlate the location of these alterations with the
classical histological features of CM. This multimodal spectroscopic
approach was performed in combination with traditional immuno-
histochemistry and biochemical techniques [enzymatic assays and
real-time polymerase chain reaction (PCR)] and forms the first study
to reveal a wealth of biochemical information at sufficient spatial
resolution to test the hypothesis that protein oxidation and anaerobic
metabolism occur at the sites of microhemorrhage and elevated cere-
bral Fe content within the cerebellum during murine CM and, by
inference, in human diseases.RESULTS
Demonstration of characteristic histological features of
murine CM
Immunohistochemical detection of the serum protein fibrinogen and
routine hematoxylin and eosin (H&E) histology were used to demon-
strate the characteristic histological features of ECM, such as immune
cell sequestration, BBB compromise, and microhemorrhage. A repre-
sentative example of immunohistochemical localization of fibrinogenFig. 1. Immunohistochemistry shows compromisedBBB and increased
fibrinogen content in the brain parenchyma of CM mice. (A and B) Im-
munohistochemical localization of the plasma protein fibrinogen in the
cerebellum of control (A) and CM (B) mice. BrownDAB staining, indicating
increased BBB compromise and leakage of the plasma protein fibrinogen
into the brain parenchyma, was observed in mice with CM. Counterstain-
ing with hematoxylin revealed numerous leukocyte nuclei within the mi-
crovessels (arrows) in CM mice. WM, white matter; GM, gray matter.2 of 13









that demonstrates increased BBB permeability to protein in ECM is
presented in Fig. 1.
Malaria parasites are not the source of elevated cerebral
lactate during murine CM
Lactate and parasite DNA content were determined via enzymatic assay
(lactate) and real-time PCR (DNA) in lung and brain homogenates
(Fig. 2L). A significant increase in brain lactate was observed in ECM
relative to controls. ECM brain lactate was significantly greater than
ECM lung lactate. No difference in lung lactate was observed between
ECM and controls. However, parasite DNA content displayed the
reverse trend to lactate, with significantly more parasite DNA present in
the ECM lung than in ECM brain tissue. Thus, there was no correlation
between the lactate concentration and the number of malaria parasites
(as indicated by parasite DNA) in these tissues, indicating that parasites
are not the source of increased brain lactate during ECM.Hackett et al. Sci. Adv. 2015;1:e1500911 18 December 2015Identification and validation of spectroscopic markers of
protein oxidation and altered metabolism for FTIRM
The use of spectroscopic marker bands centered at 1742 and 1656 cm−1
to image the relative distribution of lipids and a helix proteins, respec-
tively, in cerebellum tissue is well established (28–30, 36). Here, we
conclusively demonstrate that the second-derivative intensity of the
bands at 1627 and 1127 cm−1 from FTIR spectra collected from brain
tissue is suitable for the analysis of relative aggregated b sheet protein
(a marker of protein oxidation) and lactate content (a marker of
disturbed metabolism), respectively. The methods used to validate
these markers are presented in fig. S1.
FTIRM demonstrates elevated lactate and protein
aggregates at the site of vascular hemorrhage
Relative distributions of lipids, a helix proteins, aggregated b sheet
proteins, and lactate in the cerebellum were determined from second-Fig. 2. Multimodal biospectroscopic approach to studying the biochemical mechanisms of CM. (A to G) Biospectroscopic imaging in combination
with histology of cerebellum tissue in CM and control mice. (A) Representative example of H&E histology of cerebellum tissue from control (i) and CM (ii)
mice, highlighting the appearance of tissue edema at the site of vascular hemorrhage. (B) XFM elemental mapping of the distribution of Fe in control (i) and
surrounding hemorrhaged tissue in CM (ii) cerebellum tissue. (C) Resonance Raman mapping of the distribution of hemoglobin in control (i) and hemor-
rhaged tissue in CM (ii) cerebellum tissue. (D) FTIR imaging of the lipid (second-derivative band intensity at 1742 cm−1) distribution in control (i) and
hemorrhaged tissue in CM (ii) cerebellum tissue. (E) FTIR imaging of the lactate (second-derivative band intensity at 1127 cm−1) distribution in control
(i) and hemorrhaged tissue in CM (ii) cerebellum tissue. (F) FTIR imaging of the a helix protein (second-derivative band intensity at 1656 cm−1) distribution
in control (i) and hemorrhaged tissue in CM (ii) cerebellum tissue. (G) FTIR imaging of the aggregated b sheet protein (second-derivative band intensity at
1627 cm−1) distribution in control (i) and hemorrhaged tissue in CM (ii) cerebellum tissue. Black arrows in (Fii) and (Gii) highlight the location of elevated
aggregated b sheet/a helix protein ratio hotspots. Scale bar in (A), 50 mm. (H to K) Representative second derivatives of the average FTIR spectra from
control and CMmouse cerebellum tissue. (H) Lipid and protein alterations in the spectra from hemorrhaged and nonhemorrhaged inner white matter from
CM mice and from inner white matter of control mice. AU, arbitrary units. (I) Differences in lactate in the spectra from hemorrhaged and nonhemorrhaged
inner white matter from CM mice and from inner white matter of control mice. (J) Protein alterations in the spectra from granular layer tissue in CM mice
and control mice. (K) Protein alterations in aggregated protein “hotspots” in the spectra from granular layer tissue of CM and control mice. Upward-facing
arrows highlight spectral locations of decreased second-derivative band intensity, and downward facing arrows highlight spectral locations of increased
second-derivative band intensity. (L) Brain and lung lactate levels in CM diseased and control mice (n = 5). Parasite DNA was not detected (ND) in the brain
or lung of control mice. #Significant difference in brain lactate between CM and control mice. *Significant difference in lactate between the brain and lung
of CM mice, or between the brain and lung of control mice. †Significant difference in parasite DNA between the brain and lung of CM mice.3 of 13









derivative intensities at 1742, 1656, 1625, and 1127 cm−1, respectively.
To demonstrate that molecular alterations observed in the cerebellum
during ECM were not a consequence of terminal illness, or a response
to generalized parasite infection, brain tissues from three sets of control
animals were imaged: saline-injected mice, mice with mild malarial
anemia, and mice with terminal severe malarial anemia without
cerebral complications (see Materials and Methods for a detailed
description of the animal models).
To correlate molecular images with brain anatomy and CM pa-
thology, the false-color functional group images were overlayed with
visible light images of the H&E-stained adjacent tissue section (Fig. 2,Hackett et al. Sci. Adv. 2015;1:e1500911 18 December 2015A toG, and fig. S3). The average spectrumwas determined from regions
of interest that corresponded to specific tissue regions: molecular layer,
granular layer, inner white matter, and hemorrhaged tissue (Fig. 2). A
representative example of these regions is shown in fig. S3. An
alternative approach, using multivariate analysis, yielded similar sci-
entific conclusions (figs. S4 and S5). Comparison of average spectra
from each tissue region for each treatment group was used for statistical
evaluation of significant differences in the average relative lipid, a helix
and aggregated b sheet protein, and lactate contents (Fig. 2 andTable 1).
A significant decrease in lipid content (second-derivative intensity
of the band at 1742 cm−1) was observed at the site of hemorrhagedTable 1. Differences in relative content of lipids, a helix protein, aggregated b sheet protein, and lactate as determined from second
derivatives of FTIR band intensities for hemorrhaged inner white matter (WM HM), nonhemorrhaged inner white matter (WM), granular
layer (GL), and molecular layer (ML) from CM and sham, mild malaria anemia (MMA), and severe malaria anemia (SMA) mice. Bold indicates
a statistically significant difference (P < 0.05), relative to sham animals.Sample 1742 cm−1 (lipid) 1656 cm−1 (a helix protein) 1625 cm−1 (aggregated b sheet protein) 1127 cm−1 (lactate)CM WM HM Average −2.5 × 10−4 −2.6 × 10−3 2.3 × 10−4 1.3 × 10−5SD 1.1 × 10−5 3.5 × 10−4 3.0 × 10−5 2.0 × 10−6CM WM Average −6.6 × 10−4 −1.8 × 10−3 3.0 × 10−4 6.6 × 10−5SD 4.5 × 10−5 3.5 × 10−4 9.8 × 10−6 3.3 × 10−5Control (sham) WM Average −7.2 × 10−4 −1.8 × 10−3 3.6 × 10−4 9.1 × 10−5SD 5.2 × 10−5 1.6 × 10−4 5.9 × 10−5 1.9 × 10−5Control (MMA) WM Average −6.9 × 10−4 −1.8 × 10−3 3.3 × 10−4 8.7 × 10−5SD 2.5 × 10−5 2.6 × 10−4 2.7 × 10−5 1.4 × 10−5Control (SMA) WM Average −7.0 × 10−4 −1.8 × 10−3 3.4 × 10−4 8.6 × 10−5SD 3.5 × 10−5 3.0 × 10−4 4.3 × 10−5 1.3 × 10−5CM GL Average −2.4 × 10−4 −2.0 × 10−3 2.5 × 10−4 6.0 × 10−5SD 2.2 × 10−5 1.7 × 10−4 1.9 × 10−5 6.6 × 10−6Control (sham) GL Average −2.4 × 10−4 −2.1 × 10−3 3.0 × 10−4 5.0 × 10−5SD 2.5 × 10−5 2.7 × 10−4 8.8 × 10−6 2.0 × 10−5Control (MMA) GL Average −2.4 × 10−4 −2.1 × 10−3 2.9 × 10−4 6.0 × 10−5SD 3.0 × 10−5 2.7 × 10−4 1.5 × 10−5 3.3 × 10−5Control (SMA) GL Average −2.6 × 10−4 −2.1 × 10−3 2.7 × 10−4 5.5 × 10−5SD 2.9 × 10−5 2.7 × 10−4 9.8 × 10−6 2.5 × 10−5CM ML Average −1.6 × 10−4 −2.1 × 10−3 2.7 × 10−4 4.0 × 10−5SD 4.0 × 10−4 1.9 × 10−4 2.5 × 10−5 2.9 × 10−6Control (sham) ML Average −3.5 × 10−5 −2.1 × 10−3 2.9 × 10−4 4.1 × 10−5SD 3.4 × 10−4 1.9 × 10−4 4.2 × 10−5 6.2 × 10−6Control (MMA) GL Average −4.1 × 10−4 −2.1 × 10−3 3.0 × 10−4 4.1 × 10−5SD 7.5 × 10−5 2.0 × 10−4 4.2 × 10−5 3.0 × 10−6Control (SMA) ML Average −2.3 × 10−4 −2.2 × 10−3 2.7 × 10−4 3.8 × 10−5SD 3.9 × 10−4 1.6 × 10−4 1.1 × 10−5 5.7 × 10−64 of 13









tissue within cerebellar white matter during ECM, relative to control
white matter (Fig. 2 and Table 1). This decrease was colocalized with
an increased relative content of a helix (second-derivative intensity of
the band at 1656 cm−1), greater aggregated b sheet proteins (second-
derivative intensity of the band at 1627 cm−1), and higher lactate
(second-derivative intensity of the band at 1127 cm−1), as shown in
Fig. 2 and Table 1. Although additional lipid bands were not quanti-
fied, the decreased intensity in the lipid carbonyl band at 1742 cm−1
in hemorrhaged white matter occurred concomitant with reduced
intensity of characteristic phospholipid bands, such as nas(PO2
2−), ns
(PO2
2−), n(C–O), and n(P–O–C) at 1242, 1085, 1065, and 970 cm−1,
respectively. In addition, on average, there was a subtle, yet significant,
increase in the relative content of aggregated b sheet proteins and a
decrease in the relative content of a helix proteins in the granular layer
tissue surrounding hemorrhaged white matter during ECM (Fig. 2
and Table 1). Differences were not uniform across the granular layer
but rather occurred in discrete “hotspots” (representative spectra from
the hotspots are shown in Fig. 2). Of significance, these hotspots occurred
at the periphery of elevated brain Fe microdomains, which were notHackett et al. Sci. Adv. 2015;1:e1500911 18 December 2015hemoglobin, as determined from XFM and resonance Raman map-
ping (see below). These results from univariate spectral analysis are in
agreement with, and are further supported by, multivariate analysis of
the data (principal components analysis), presented in figs. S4 and S5.
Additional analyses showed that the scientific conclusions drawn from
these results were not influenced by spectral artifacts caused by reso-
nant Mie scattering or electric field standing wave artifacts (fig. S6).
Elemental mapping of Fe distribution around hemorrhaged
microvasculature shows spread of Fe from hemorrhage
into brain parenchyma
After FTIRM, elemental maps (P, S, Cl, K, Ca, Fe, Cu, and Zn) were
obtained from XFM mapping of the same sections to determine
whether FTIR spectroscopic markers of protein oxidation observed
in the CM mice colocalized with elevated tissue Fe. A preliminary
study used XFM and PIXE elemental mapping to validate the ability
to resolve Fe distribution in healthy and hemorrhaged cerebral blood
microvessels (see figs. S7 and S8). A representative example of the
elemental distribution across ECM and control cerebellum (5-mm stepFig. 3. XFM analysis of the elemental alterations in the cerebellum during murine CM. (A and B) XFM elemental maps (P, S, Cl, K, Ca, Fe, Cu, and Zn)
collected with a 5-mm step size of the cerebellum of control (A) and CM (B) mice. H&E histology is presented for the entire cerebellum and at sites of
healthy and hemorrhaged vasculature. IL, inner layer (white matter); GL, granular layer (gray matter). Arrows indicate the location of healthy vasculature in
controls (black) and hemorrhaged (white) vasculature in ECM. (C and D) High–spatial resolution XFM elemental maps (P, S, Cl, K, Ca, Fe, Cu, and Zn)
collected with a 0.5-mm step size of the cerebellum of control (C) and CM (D) mice. H&E histology is presented for the sites of healthy and hemorrhaged
vasculature, indicated by black arrows. Note that high relative Fe content is only observed within the microvessel in the sham animal (similar to the
preliminary investigation, fig. S8), whereas high Fe is observed throughout the white matter in the CM mouse, with low Fe observed in the white matter
surrounding the vessel. IL, inner layer (white matter); GL, granular layer (gray matter).5 of 13









size), together with high-resolution maps (0.5-mm step size) of healthy
cerebral blood microvessels and microhemorrhage, is presented in
Fig. 3. Visual examination of the elemental maps provided discrimi-
nation between the different cerebellar tissue layers. The average
elemental concentrations for each tissue region (molecular layer,
granular layer, inner layer, and hemorrhaged tissue) were quantified
from XFM elemental maps (Fig. 4). As can be seen from the elemental
maps and average elemental concentrations, significantly increased Fe
and significantly decreased P content were observed at the site of
hemorrhaged white matter tissue in ECM relative to controls (Figs. 3
and 4). Further, as evident in the Fe map, the elevated Fe was not
confined to the region identified as “hemorrhaged” tissue based on
histology but extended into the surrounding granular layer tissue. No-
tably, the highly localized regions of elevated aggregated b sheet protein
content were observed at the periphery of the Fe microdomain (Fig. 3).
Resonance Raman mapping of the distribution of
hemoglobin around hemorrhaged microvasculature reveals
elevated nonheme-bound Fe in brain parenchyma
surrounding hemorrhaged tissue
The highest total Fe content in ECM brain tissue can be found at the
center of themicrohemorrhage, colocalized with the highest concentra-
tion of hemoglobin (Fig. 2). Further, the resonance Raman map of he-
moglobin showed a similar distribution to hemorrhaged tissue, as
seen by the loss of lipid and P from the white matter and from his-
tological examination of the H&E-stained tissue section. No resonance
Raman signal from hemoglobin or any other heme moiety colocalized
with the regions of elevated Fe was observed in the granular layer tissue,
which surrounded the hemorrhagedwhitematter tissue in ECM.A repre-
sentative example of a Raman spectrum from the hemorrhaged tissue that
shows the characteristic hemoglobin bands is presented in fig. S9.DISCUSSION
Long-debated mechanistic controversies on the biochemical
mechanisms of CM pathogenesis
Classical histological features of CM, common to human and ECM,
are (i) sequestration of PRBCs and immune cells (leukocytes and
monocytes) within cerebral blood microvessels, (ii) compromisedHackett et al. Sci. Adv. 2015;1:e1500911 18 December 2015BBB, and (iii) microhemorrhage (4, 12, 13). These pathologies suggest
that reduction or loss of blood flow due to vascular obstruction caused
by sequestered cells or hemorrhage would result in hypoxia/ischemia
and contribute to disease pathogenesis (8, 15, 16, 18, 46–48). In ad-
dition, release of Fe into the brain parenchyma following microhe-
morrhage may mediate free radical production and peroxidative
stress through classic Fenton chemistry and may contribute to dis-
ease morbidity and mortality as proposed, but not proven, by others
(8, 16–18, 46–48). As the disease pathology is localized to the micro-
vasculature, direct biochemical proof of disturbed energy metabolism
and peroxidative stress has been difficult to obtain with traditional
methods (7, 8, 18, 19, 47). For example, although there is a known
net increase in cerebral lactate during CM, it is not known whether this
is a uniform global change or a site-specific increase. Likewise, although
administration of antioxidants before hemorrhage prevented ECM,
increased levels of oxidized proteins or other oxidation products have
not been detected in bulk assays (8, 17, 18, 47). Further, direct bio-
chemical markers of altered metabolism and peroxidative stress, such
as lactate and high–molecular weight protein aggregates, are essentially
“invisible” to the traditionally used imaging modalities such as electron
microscopy, visible light microscopy, and fluorescence microscopy.
Consequently, the exact location and role of ischemia and peroxidative
stress during CM have long remained controversial and unresolved.
Elevated brain lactate during CM is of host, not parasite,
origin and is colocalized at the site of tissue hemorrhage
Occurrence of elevated brain lactate is well established in CM, yet the
exact location remains unknown (5–10, 19, 25, 46). Elevated lactate
observed previously in brain tissue homogenates and CSF may have
been due to a low-level uniform increase or to localized regions of
significant elevation. Recent studies in ECM suggest the latter, with
reduced brain oxygen and hypoxic conditions identified at discrete
foci (49). Several factors may contribute to elevated brain lactate during
CM, including lactate production by malaria parasites or ischemic brain
tissue, response to cytopathic hypoxia and inflammatory cytokines,
or leakage from serum due to increased BBB permeability and micro-
hemorrhage (4, 7, 8, 12, 13, 19).
This investigation demonstrated that malaria parasites are not the
dominant source of elevated lactate during CM. We cannot rule out a
lactate contribution derived from PRBCs sequestered within brainFig. 4. XFM elemental concentrations showing a significant difference in the P and Fe concentrations observed in hemorrhaged white
matter tissue in CM mice, relative to healthy molecular layer, granular layer, and white matter tissue in control mice (n = 5). *Significant
difference relative to control tissue. IL, inner layer (white matter); GL, granular layer (gray matter); ML, molecular layer; HM, hemorrhaged tissue.6 of 13









blood microvessels. However, this study showed a large number of
parasites within the lung during CM but no accompanying increase
in lactate relative to control mice, whereas greater lactate was observed
in CM brain tissue where parasite numbers were lower than those in
the lung (Fig. 2). Therefore, elevated brain lactate during ECM must
have been of host and not parasite origin and was likely to have
resulted from hypoxic and/or ischemic brain tissue. This result was
in strong agreement with two previous investigations that demon-
strated reduced oxygen content in tissue surrounding microhemor-
rhages (49) and increased occurrence of crystalline creatine deposits
in cerebellum tissue, a characteristic marker of ischemia, during
ECM (29). Further, we demonstrate that elevated lactate was not
uniform but occurred at the site of microhemorrhage (Fig. 2). This
result highlighted that generation of lactate by brain cells in response
to hypoxia, ischemia, or inflammatory cytokines, or serum-derived
lactate, may contribute to elevated brain lactate. Although the
methods used in this study did not discriminate between these
possibilities, the highly localized nature of elevated lactate at the
site of tissue hemorrhage demonstrated that brain ischemia and
altered metabolism were not uniformly present in ECM brains but,
rather, were likely to colocalize with damaged vasculature. Previous
studies have shown a direct correlation between brain lactate and
disease severity (5, 9). Likewise, declining brain function has been
shown to correlate with the number of hemorrhagic events that
occurred during CM (50). This study has demonstrated a direct cor-
relation between elevated cerebral lactate and microhemorrhage, thus
providing a link between the previous observations.
Fe-mediated Fenton chemistry, peroxidative stress, and
protein oxidation are components of CM pathogenesis
A novel multimodal biospectroscopic imaging approach allowed the
distribution of important biological parameters to be assessed at mi-
crometer spatial resolution, in relation to classical histological features
of murine CM. This confirmed lipid loss at the location of edema and
microhemorrhage within white matter as demonstrated in the FTIRM
lipid (Fig. 2) and elemental P maps (Fig. 3). The appearance of serum
proteins in brain parenchyma due to BBB leakiness was confirmed by
immunohistochemistry for the serum protein fibrinogen (Fig. 1).
Because of the high content of a helix secondary structure in most
serum proteins, it is not surprising that FTIRM revealed a large in-
crease in the relative content of proteins with this feature at the site of
tissue microhemorrhage.
Of greater interest in this investigation was an increase in the rel-
ative content of aggregated b sheet proteins colocalized at the site of
tissuemicrohemorrhage and at the periphery of parenchymalmicro-
domains containing Fe (Fig. 2). Two physiological sites of protein
oxidation, one at the site of tissue hemorrhage and another at the
furthest extent of elevated parenchymal Fe, may initially seem count-
erintuitive. However, this agrees with the known pathology of vas-
cular damage, red blood cell lysis, hemoglobin degradation, and
Fenton chemistry. First, because of substantial inflammation and
immune cell sequestration within the bloodmicrovessels, free radical
production is likely to be increased because of localized ischemia or
cytokine-mediated release of reactive oxygen species from immune
cells (15, 18, 47, 51, 52). Therefore, one would expect oxidation of
proteins and the formation of high–molecular weight protein aggre-
gates at the site of microhemorrhage. Following hemorrhage, most
of the hemoglobin released into the brain tissue may not be imme-Hackett et al. Sci. Adv. 2015;1:e1500911 18 December 2015diately damaging; however, upon hemoglobin breakdown, liberation of
redox-active free Fe(II) may saturate native antioxidant mechanisms
through classical Fenton chemical pathways (53, 54). We hypothesize
that Fe, which has spread furthest into the brain from the site of
hemorrhage, has spent the longest time in the parenchyma,most likely
originates from degraded hemoglobin, is redox-active, and may have
reached tissue that is sufficiently distant from the vasculature that is
yet to up-regulate levels of defensemechanisms to combat Fe-mediated
oxidative stress. The results from this investigation provide strong
support for this theory: Elemental mapping revealed elevated Fe at
the site of hemorrhage as well as spreading into the surrounding brain
parenchyma; resonance Raman mapping demonstrated that only Fe
at the site of tissue hemorrhage, but not Fe in the surrounding brain
parenchyma, was heme-bound; and FTIRM showed that there was a
significant increase in the relative content of aggregated b sheet pro-
teins colocalized with the boundary of elevated parenchymal non-
heme Fe. Hence, this is the first study to provide direct evidence for
Fe-mediated Fenton chemistry, peroxidative stress, and protein ox-
idation following microhemorrhage during CM. These results may
help explain some of the success of deferoxamine Fe chelation ther-
apy in reducing coma in children with CM (55). However, the exact
mechanism of action of Fe chelation therapy is not fully understood,
and it is not known whether Fe chelation acts via reduction of free Fe
in the brain parenchyma, thus reducing oxidative stress, or whether
Fe chelation acts to reduce parasitemia through Fe starvation of the
parasite (55, 56). Although some success in minimizing patient coma
with Fe chelation therapy has been achieved, other studies have shown
no effect on patient morbidity (56). Therefore, the results of this study
indicate that new therapies specifically targeted to chelate free Fe,
minimize oxidative stress, and minimize BBB breakdown may provide
substantial patient benefit.
The combination of resonance Raman spectroscopy and XFM
allowed identification of elevated nonheme Fe in tissue surrounding
microhemorrhage. The enhanced scattering signal that arises from
resonance Raman spectroscopy has been used to map oxyhemoglobin
and deoxyhemoglobin in blood vessels (43–45). In this investigation, a
similar approach was used to map the distribution of hemoglobin at
the site of microhemorrhage in ECM mice. Representative resonance
Raman spectra from hemorrhaged tissue and from dried red blood
cells are presented in fig. S9. On the basis of the appearance of
the strong band at 1376 cm−1, oxyhemoglobin was likely to be
the dominant form present (43–45). However, a small band is also
observed at ~1358 cm−1, indicating some contribution from deox-
yhemoglobin (43–45). It is assumed that during the chemical reaction
characteristic of Fenton chemistry, the Fe ions will redox cycle and
both ferric and ferrous forms will be present. Future studies may
incorporate x-ray absorption spectroscopy speciation studies (57)
to determine the relative proportions of ferric and ferrous Fe in heme
and nonheme forms present in the brain parenchyma surrounding
tissue hemorrhage.CONCLUSIONS
The multimodal spectroscopic approach (FTIRM, PIXE, XFM, and
resonance Raman spectroscopy) in combination with traditional
histology, immunohistochemistry, and biochemical assays used in this
study provided the unique capability of detecting an unprecedented
level of biochemical and pathological information regarding disease7 of 13
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nloaded frommechanisms of CM. Specifically, the results provide the first direct
evidence that elevated levels of anaerobic metabolites are not a
uniform global condition during murine CM and are highly localized
at the site of tissue microhemorrhage. In addition, this study shows
the first strong, and direct, evidence for Fe-mediated protein oxidation
following hemorrhage and hemoglobin breakdown during CM. These
results are potentially valuable for future development of improved
therapies for CM and indicate that anti-inflammatory therapy to
prevent/minimize BBB damage and hemorrhage, development of
greater efficacy of antioxidant delivery to the site of hemorrhage,
and/or up-regulation of the native brain antioxidant capacity, such
as neuroglobin (58), may result in improved patient outcome. The
FTIR and resonance Raman spectroscopic techniques used in this
study have a short penetration depth (typically <20 mm) and are not
suitable for in vivo diagnostics or biochemical analysis in humans.
However, continued development of micro–attenuated total reflection
(micro-ATR) FTIR devices and fiber-optic Raman probesmay allow, in
the near future, biochemical information similar to that reported in this
study to be detected in real time in vivo. This may provide significant
benefit in identifying the extent of disease progression and the admin-






This study used validated mouse models to generate ECM, experimen-
tal nonfatal mild malaria anemia without cerebral complications
[experimental mild malaria anemia (EMMA)], experimental fatal
malaria anemia without cerebral complications [experimental severe
malaria anemia (ESMA)], and sham controls (7, 8, 29). Tissue harvest-
ing and preparation of brain tissue were performed as in the Supple-
mentary Materials, as described previously (30). The left hemisphere
of the cerebellum was homogenized in phosphate-buffered saline
(PBS) at 4°C, the supernatant was retained for biochemical assay of
lactate (using the protocol described in the Supplementary Materials),
and the pellet was retained for assay of host and parasite DNA content
(using the protocol described in the Supplementary Materials). Four
adjacent 10-mm-thick tissue sections were cut from the right hemi-
sphere and mounted on a Si3N4 window for FTIRM/XFM analysis
(27), on an aluminum slide (prepared in-house) for Raman spectro-
scopic analysis, and on standard glass microscope slides for routine
H&E staining. Additional tissue sections were cut for further investiga-
tion of the elemental composition of blood vessels and scattering ar-
tifacts in FTIR spectra and for immunohistochemistry of plasma
proteins (as described below).
FTIRM with a focal plane array detector was performed using
equipment and protocols as described previously (29, 30), and de-
scribed in detail below. In general, images were collected from an area
of the cerebellum ranging from 170 mm×170 mm to 680 mm× 680 mm,
containing all three tissue layers (molecular layer, granular layer, and
inner white matter). Following FTIRM, tissue sections were freeze-dried,
and elemental mapping was performed on one set of tissue sections
using PIXE and on the other set of tissue sections using XFM. Raman
spectroscopic mapping was performed using 514-nm excitation, as
described in detail in the Supplementary Materials. Following spec-
troscopic analysis, tissue sections were stained withH&E, in addition
to the tissue section mounted on the glass microscope slide for routine
histology.Hackett et al. Sci. Adv. 2015;1:e1500911 18 December 2015The average molecular and elemental compositions were
determined from regions of interest corresponding to hemorrhaged
tissue, molecular layer, granular layer, and inner white matter, identi-
fied by a trained pathologist. A Student’s t test and 95% confidence
limit were used to test for a significant difference between groups.
Animal models
All animals were 6-week-old female C57/B6 mice, given food and
water ad libitum, and all experiments were approved by The Univer-
sity of Sydney Animal Ethics Committee and strictly followed Institu-
tional Animal Care and Use Committee guidelines. ECM was induced
in mice (n = 6) via intraperitoneal injection of diluted erythrocytes
(200 ml) containing the malaria parasite Plasmodium berghei ANKA
(59, 60). Experimental mild (noncerebral) malaria anemia and ex-
perimental severe (noncerebral) malaria anemia were induced in mice
(n = 6 for both EMMA and ESMA) via intraperitoneal injection of
diluted erythrocytes (200 ml) containing the malaria parasite P. berghei
K173 (PBK) (60–62). In both cases, the 200-ml aliquot of blood
contained a PRBC count of approximately 1 × 106. Sacrifice of
mice infected with PBK at day 6 after inoculation equated to the
mild anemia model, and sacrifice of mice at day 12 after infection
equated to the severe anemia model (62, 63). Control (sham-
infected) mice (n = 6) were injected with 200 ml of PBS via intra-
peritoneal injection.
Mice were examined for visual signs of illness at day 6 (ECM and
EMMA) and day 12 (ESMA) after infection. EMMA mice displayed
no visual signs of cerebral complications at day 6, and ESMA mice
displayed no signs of cerebral complications at day 12 after infection.
At day 12 after infection, ESMA mice displayed visual signs of severe
malaria anemia (lethargy, hunched posture, and ruffled fur) (60–62).
At day 6, ECM mice displayed signs of cerebral complications (im-
paired movement, impaired balance, and convulsions) (59, 61).
Blood hematocrit and parasite counts were in the following ranges:
sham mice, 40 to 50% and 0%, respectively; ECM and EMMA
mice, 20 to 35% and 8 to 20%, respectively; ESMA mice, <15%
and >50%, respectively [all were consistent with our previous reports
(7, 60, 61)].
Tissue collection
Sham, ECM, andEMMAmicewere sacrificed and brainswere collected
6 days after infection, and ESMA mice were sacrificed 12 days after
infection. Mice were anesthetized by inhalation of isoflurane vapor
before sacrifice andwere euthanized by cervical dislocation. Immediate-
ly after sacrifice, mouse brains were removed and the cerebellum was
obtained and cut in half along the sagittal plane. The left hemisphere
was immediately snap-frozen in liquid N2 and the right hemisphere
was embedded in optimal cutting temperature medium and snap-
frozen in a liquid nitrogen–cooled hexane slurry. In addition, the lungs
of ECM mice were removed and snap-frozen in liquid nitrogen. All
samples were stored at −80°C until required for analysis.
Tissue homogenization
Lung tissue and the left cerebellar hemisphere of control and ECM
diseased mice were homogenized separately in 200 ml of PBS at 4°C.
A 200-ml aliquot of each homogenate was centrifuged at 16,000g for
20 min at 4°C. The pellet was retained for parasite DNA analysis, and
the supernatant fraction was retained for enzymatic lactate assays and
bulk FTIR spectroscopic analyses.8 of 13










Parasite levels in brain and lung tissue were compared by calculating
the ratio of a parasite gene to a mouse gene. The pellet from brain
homogenates was resuspended in 200 ml of tissue lysis buffer (supplied
with kit) and DNA was purified using the High Pure PCR Template
Preparation Kit (Roche Applied Science). PCR amplification was
performed using 1× ImmoMix (Bioline), 200 nM primer, and 1×
SYBR Green I (Life Technologies) in a Rotor-Gene3000 (Corbett
Research). The touchdown PCR amplification protocol comprised
35 cycles of 95°C for 15 s, 60°C (decreasing to 55°C over 6 cycles) for
15 s, and 72°C for 15 s. Purity of PCR products was assessed by melt-
ing curve analysis, and a standard curve derived from serial dilution
of DNA from infected tissue was used to measure the levels of the
host and parasite genes. P. berghei gene: carbamoyl phosphate syn-
thetase II AF286897.1 (forward, TAAAACTGCTATTCAAACCGCC;
reverse, GCTACCCCATTCTAGTGCGTACT). Mus musculus gene:
tyrosine 3-monooxygenase activation protein, zeta polypeptide
NM_001253807.1 (forward, TGTCACCAACCATTCCAACTTG; re-
verse, ACACTGAGTGGAGCCAGAAAGA).
LDH assay
Lactate concentrations in the supernatant fraction of cerebellum
homogenates were determined using the Eton Bioscience enzymatic
lactate assay kit. In general, lactate and NAD+ (nicotinamide adenine
dinucleotide) in each sample were converted into pyruvate and NADH
(reduced form of NAD+) by LDH. A tetrazolium salt was then reduced
to formazan in an NADH-coupled enzyme reaction. The concentra-
tion of formazan (which is proportional to the lactate concentration)
was quantified by spectrophotometric measurement at 490 nm.
Determination of FTIRM spectroscopic markers of lactate
Supernatant solution (100 ml) from control mice and ECM diseased
mice was analyzed either without chemical modification or after
the addition of 56 mg of lactate (C3H5O3Na, Sigma-Aldrich). An ad-
ditional solution was prepared via the addition of 10 ml of LDH
(Sigma-Aldrich) to 100 ml of the supernatant, and 1-ml aliquots were
harvested for analysis at 1- and 5-min time points after LDH addi-
tion. FTIR spectroscopic analysis was performed on 1-ml aliquots of
each solution.
Determination of FTIRM spectroscopic markers of
protein oxidation
Spectroscopic markers of protein oxidation were analyzed from
spectra collected from the supernatant solution of brain homogenates
from control and ECM diseased mice and incubated without chemical
modification or following incubation with 1 mM Fe(II) (FeSO4) or Fe(II)
in the presence of 5 mM Desferal for 40 min. FTIR spectroscopic
analysis was performed on 1-ml aliquots of each solution.
Bulk FTIR spectroscopic analyses
Bulk FTIR spectra were acquired from dried films prepared from the
supernatant fractions of cerebellum homogenates. A 1-ml aliquot of
each sample was transferred onto an infrared transparent silicon 96-
well microtiter plate (each sample was analyzed in triplicate). Aliquots
were spread over an area of approximately 50mm2 and allowed to air
dry for a period of 30 min to produce a dried film. FTIR analyses of
the dried films were performed using a Bruker Tensor 27 FTIR spec-
trometer fittedwith a high-throughput sampling accessory (HTS-XT),Hackett et al. Sci. Adv. 2015;1:e1500911 18 December 2015a thermal glowbar infrared source, and a mercury cadmium telluride
detector. Spectra were collected over the range 400 to 4000 cm−1 at a
resolution of 4 cm−1, with the co-addition of 256 scans per spectrum.
A background spectrum was taken before each sample measurement
using the same parameters as above.
Preparation of tissue sections: Complementary multimodal
spectroscopic imaging
Four adjacent 10-mm-thick sections of cerebellum tissue were cut
from the right-hand hemisphere of cryo-preserved cerebellum tissue
from control, ECM, EMMA, and ESMA diseased mice. Tissue sec-
tions were cut at −14°C with a cryotome (Thermo Shandon). Two
sections were melted onto Si3N4membranes (Silson Ltd.) for FTIRM
and XFM analyses. The dimensions of the Si3N4 windows are as
follows: membrane size, 5 mm × 5 mm; membrane thickness, 500 nm;
Si frame size, 10 mm × 10 mm; and frame thickness, 200 mm. Imme-
diately after FTIR analysis of the sections mounted on Si3N4 win-
dows, the sections were freeze-dried under vacuum at −80°C for
12 hours. The third section wasmounted onto a thin sheet of Al (pre-
pared in-house) for Raman spectroscopic analyses. The fourth sec-
tion was mounted onto a standard glass microscope slide and fixed
in 4% phosphate-buffered formalin (Sigma-Aldrich) for routine his-
tological analysis.
Preparation of tissue sections for figs. S5 to S7
Three tissue sections were collected for preliminary studies: to confirm
that compromised BBB was present in ECM diseased mice (section A),
to determine the elemental distribution and morphology of cerebral
blood vessels in elemental maps (section B), and for synchrotron
radiation FTIRM investigation of the protein signature in ECM
cerebellum tissue (section C). Two 7-mm-thick sections (A and C)
and one 10-mm-thick cerebellum tissue section (B) were cut from each
brain and mounted on a standard glass microscope slide (A), Si3N4
window (B), and low E Kevley slide (C). Tissue sections were freeze-
dried as described previously. These tissue sections were cut at a posi-
tion approximately 100 to 200mmmedial compared to the four adjacent
sections described earlier.
FTIRM of cerebellum tissue sections with a focal place
array detector
Images were acquired using a Bruker Vertex 80v FTIR spectrometer,
coupled to a Hyperion 3000 microscope. The microscope is equipped
with a liquid nitrogen–cooled 64 × 64 focal plane array detector. Opus
software (version 6.5, Bruker) was used for instrument control and
data collection. Spectra were acquired with the co-addition of 64 scans
at 4 cm−1 resolution over the range 3600 to 900 cm−1. Images were
collected in transmission mode using a 15× microscope objective and
2 × 2 pixel binning. The sampling area ranged from 170 mm × 170 mm
(1024 spectra) to 680 mm × 680 mm (16,384 spectra). All data were
collected from a region within the brain cerebellum containing the
molecular, granular, and inner white matter layers. A background
image (1024 spectra) was collected from a blank Si3N4 substrate before
the collection of each sample image.
Synchrotron radiation FTIRM of cerebellum tissue
sections (fig. S5)
Cerebellum tissue was mounted on a Kevley slide and analyzed in the
mid-IR region. Data were collected over 4000 to 800 cm−1 with the9 of 13









co-addition of 128 scans on a Bruker Vertex 80v FTIR spectrometer
with a 36× objective and a mercury cadmium telluride detector.
Maps were collected with an aperture beam spot of 5 mm and a
step size of 5 mm.
Streamline Raman spectroscopic mapping
Raman spectroscopic maps were acquired from 10-mm-thick tissue
sections mounted on thin Al sheets. Raman spectroscopic maps were
acquired following FTIR measurements using StreamLine mapping
(Renishaw plc.) on a Renishaw Raman inVia Reflex spectrometer
and controlled with Renishaw WiRE software (Renishaw, WiRE,
version 3.2). The inVia Reflex spectrometer was equipped with
an air-cooled charge-coupled device camera and a Leica DMLM
microscope. Sample excitation was achieved using an Ar+ laser
(Modu-Laser) emitting at 514.5 nm. Wave number calibration was
achieved against the reference Si sample (Si band position, 520.5 ±
0.1 cm−1). Stokes Raman spectra were collected using a grating of
1200 lines per mm across the spectral range of 1900 to 650 cm−1.
Spectra were collected with a 50× microscope objective, using 100%
laser power, with an accumulation time of 10 s and an effective step
size of 5 mm. The size of the maps collected ranged from 100 mm ×
100 mm to 500 mm × 500 mm.
Elemental mapping with XFM at the Advanced
Photon Source
Following FTIRM experiments, both sets of the 10-mm-thick tissue
sections mounted on Si3N4 were immediately freeze-dried under
vacuum conditions (12 hours at −80°C). The freeze-dried sections
were stored on a desiccant, in the dark, at ambient conditions until
required for elemental analyses with XFM or PIXE. Two-dimensional
spatial maps of elements (P, S, Cl, K, Ca, Fe, Cu, and Zn) were
determined for the 10-mm-thick freeze-dried tissue sections. All
XFM measurements were performed at the 2-ID-E beamline at the
Advanced Photon Source (APS), Argonne National Laboratory.
X-ray fluorescence spectra were collected under a He atmosphere
using monochromatic x-ray excitation (10 keV). The incident (excita-
tion) beam was focused to 0.7 × 0.8 mm2 with a single zone plate and
order sorting aperture device (63, 64). Fluorescence was detected 90° to
the incident beam using a Si-drift detector (Vortex EM single-element
SDD). Elemental maps of the entire cerebellum “fly scan maps” (65)
(~3 × 3 mm2) were collected with 4-mm steps and a 40-ms dwell time
before fine (high-resolution) elemental maps over an approximate
area of interest of 200 × 200 mm2, with 0.7-mm steps and a 0.5-s dwell
time.
Elemental mapping with XFM at the Australian Synchrotron
Freeze-dried tissue sections mounted on Si3N4 windows were ana-
lyzed at the XFM beamline at the Australian Synchrotron (66) to
determine the elemental distribution of cerebral blood vessels.
Two-dimensional spatial maps of elements (P, S, Cl, K, Ca, Fe,
Cu, and Zn) were determined for the 10-mm-thick freeze-dried tissue
sections. X-ray fluorescence spectra were collected in air using
monochromatic x-ray excitation (10 keV). The incident (excitation)
beam was focused to 2 × 2 mm2 full width at half maximum with a
Kirkpatrick-Baez mirror pair. Fluorescence was detected 90° to the
incident beam using a Si-drift detector (Vortex EM single-element
SDD). Elemental maps were collected with 2-mm steps and a 4-s
dwell time.Hackett et al. Sci. Adv. 2015;1:e1500911 18 December 2015PIXE elemental analyses
All m-PIXE analyses were performed using the Australian Nuclear
Science and Technology Organization (ANSTO) High Energy Heavy
Ion Microprobe (67–69). Analysis was performed with a 3-MeV
proton beam and a 3- to 5-mm spot size. X-ray fluorescence spectra
were collected over a 3 mm × 3 mm area using a high-purity Ge
detector with an active area of 100 mm2. The detector was mounted
at 90° to the incoming beam and the sample was mounted at 45° to
the incoming beam. To reduce low-energy x-rays and to prevent
scattered protons from entering the detector, a 100-mm-thick
Mylar foil was placed in front of the detector. Elemental maps
(P, S, Cl, K, Ca, Fe, Cu, and Zn) were collected from the same
tissue regions analyzed using FTIR spectroscopic imaging. An ob-
sidian standard (NBS 278) was used for calibration of the x-ray
yield to allow quantitative measurements. The standard was mixed
with 20% ultrapure carbon and pressed into a pellet to avoid
charging.
H&E staining
The morphology and distribution of cerebral vessels, cell nuclei,
collagen, and white matter were determined from H&E staining
(70). Following staining, optical images were captured using a
4×, 10×, and 40× objective on an Olympus DP70 microscope con-
trolled by DP Manager software (version 1.1.1.71, 2001 Olympus
Optical).
Immunohistochemical staining of fibrinogen
The distribution of fibrinogen in the cerebellum tissue, as a marker of
plasma proteins released into the brain due to compromised BBB,
was studied with immunohistochemical staining following methods
described previously (60, 71). Following staining, optical images
were captured as described above.
Data processing of bulk FTIR spectra of dried films
Data analyses were performed using Opus Viewer 5.5 (Bruker Optic).
Because of variation in the thickness of dried films, all spectra were
preprocessed via vector normalization to the amide I band (1690 to
1610 cm−1). Second-derivative spectra were calculated from the nor-
malized spectra using a nine-point Savitzky-Golay smoothing
function.
Determination of regions of interest around cerebellar
tissue layers
To determine the average molecular or elemental composition of
cerebellar white matter, molecular layer, granular layer, and hemor-
rhaged vessels, overlap of FTIR functional group images or elemental
maps with the adjacent H&E-stained section was performed and
anatomical regions were defined. For FTIR functional group
images, one further step—hierarchical cluster analysis—was performed,
which was found to cluster spectra into the anatomical regions defined
by overlay with the H&E image.
Fourier transform infrared microscopy
False-color functional group images were generated from inverted
band intensities in second derivatives of the FTIR spectra using Cy-
tospec version 1.2.04 software. The average spectrum from each
tissue layer was calculated via a four-group Hierarchical Cluster Analysis
(1700 to 1000 cm−1) and viewed using Opus Viewer 5.5.10 of 13






Raman spectroscopic data analyses
Cosmic rays were removed from Raman spectra using a nearest-
neighbor cosmic ray removal method (Renishaw WiRE 3 software
tool). Noise-filtered Raman spectra were generated using a combina-
tion of direct classical least squares (Renishaw WiRE 3 component
analysis) and alternating least-squares multivariate curve resolution
(Renishaw’s Empty Modelling method). False-color functional group
maps were then generated from the noise-filtered Raman spectra
using Renishaw WiRE software (Renishaw, WiRE, version 3.2).
XFM data analyses
Quantitation (elemental area densities in micrograms per square centi-
meter) of P, S, Cl, K, Ca, Fe, Cu, and Znwas performed using theMAPS
software package (version 1.6.5.03) by fitting the full fluorescence
spectrum at every single point to modified Gaussians and comparing
it with corresponding measurements on the thin-film standards NBS-
1832 and NBS-1833 from the National Bureau of Standards/National
Institute of Standards and Technology (72). The statistical significance
of changes in the elemental content of treated cells compared to controls
was assessed using Student’s t test and a 95% confidence limit.
PIXE spectroscopic data analyses
Spectra from m-PIXE maps were fitted and elemental concentrations
[P, S, Cl, K, Ca, Fe, Cu, and Zn (in parts per million)] were deter-
mined using GeoPIXE software (67–69). The Bremsstrahlung
background was fitted for a light element ratio of C10O5H2 and a
density of 1.9.
Statistical analyses
Significant differences between band area and elemental concentration




Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/1/11/e1500911/DC1
Text
Fig. S1. Validation of second-derivative band intensity at 1127 cm−1 in the FTIR spectra as a
marker for relative lactate concentration.
Fig. S2. Validation of second-derivative band intensity at 1627 cm−1 in the FTIR spectra as a marker
for relative concentration of aggregated b sheet proteins and, therefore, protein oxidation.
Fig. S3. Correlation of FTIR maps of lipid distribution with H&E histology.
Fig. S4. HCA analysis of FTIR maps distinguishes four distinct regions: the molecular layer, granular
layer, inner white matter, and hemorrhaged white matter.
Fig. S5. Principal components analysis of the average spectra for tissue layers determined from
the HCA.
Fig. S6. Synchrotron radiation–based (SR) FTIR mapping of cerebellum tissue to identify Mie
scattering and electric field standing wave spectral features.
Fig. S7. SR x-ray fluorescence elemental maps (2-mm step size) of healthy cerebellum blood
vessels, showing location of Fe (white arrow) within the wall of the blood vessel.
Fig. S8. PIXE elemental maps of healthy and hemorrhaged cerebellum blood vessels.
Fig. S9. Resonance Raman spectra (514-nm excitation) collected from hemorrhaged tissue and
dried red blood cells, showing characteristic enhanced intensity of hemoglobin bands.
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